Drug Discovery · Cardiometabolic Therapeutics
Structure Therapeutics news and milestones
Structure Therapeutics: 12 headlines on record, 8 headlines in the last 90 days.
Data updated Nov 16, 2026 · Back to the company report
12Headlines
8In 90 days
0Milestones
Headlines
Nov 122026
News · YahooFinance
Retrospective analysis at ObesityWeek will explore how AI-based modeling can provide context for longer-term obesity study resultsSAN FRANCISCO, CA / ACCESS Newswire / November 1…
Nov 122026
News · FinanzNachrichten.de
Retrospective analysis at ObesityWeek will explore how AI-based modeling can provide context for longer-term obesity study results SAN FRANCISCO, CA / ACCESS Newswire / November…
Nov 112026
Press release · The Globe and Mail
Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.
Nov 102026
News · YahooFinance
Phase 3 ACCOMPLISH-1 and ACCOMPLISH-2 registrational clinical trials of aleniglipron (oral small molecule GLP-1 receptor agonist) enrolling; topline data expected in 2H 2028 Addi…
Nov 92026
Nov 32026
Oct 202026
News · markets.businessinsider.com
SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company d...
Mar 272026
News · seekingalpha.com
Feb 252026
News · The Motley Fool
Structure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care.
Nov 13, 20242024
Blog
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Structure Therapeutics.
Sources: the outlets named on each headline, each story once
How to cite
Structure Therapeutics, News. Alion, Nov 16, 2026. https://alion.io/company/structuretx/news
